Annual Long Term Debt
N/A
December 1, 2024
Summary
- EW annual long term debt is not available.
Performance
EW Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Long Term Debt
N/A
December 1, 2024
Summary
- EW quarterly long term debt is not available.
Performance
EW Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Long Term Debt Formula
Long-Term Debt = Bonds Payable + Long-Term Loans + Mortgage Payable + Other Long-Term Borrowings − Current Portion of Long-Term Debt
EW Long Term Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | - | - |
| 5 y5 years | - | - |
EW Long Term Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time |
Edwards Lifesciences Long Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $682.50 M(+1.6%) |
| Jun 2024 | - | $671.50 M(-0.4%) |
| Mar 2024 | - | $674.40 M(+0.7%) |
| Dec 2023 | $670.00 M(+0.6%) | $670.00 M(+0.5%) |
| Sep 2023 | - | $666.80 M(+1.0%) |
| Jun 2023 | - | $660.20 M(-0.4%) |
| Mar 2023 | - | $662.70 M(-0.5%) |
| Dec 2022 | $665.80 M(+0.2%) | $665.80 M(+0.4%) |
| Sep 2022 | - | $663.30 M(+0.6%) |
| Jun 2022 | - | $659.50 M(-0.7%) |
| Mar 2022 | - | $664.30 M(-0.1%) |
| Dec 2021 | $664.80 M(-0.4%) | $664.80 M(+0.7%) |
| Sep 2021 | - | $659.90 M(+0.1%) |
| Jun 2021 | - | $659.10 M(-0.5%) |
| Mar 2021 | - | $662.30 M(-0.8%) |
| Dec 2020 | $667.70 M(+2.2%) | $667.70 M(+0.3%) |
| Sep 2020 | - | $665.90 M(+0.8%) |
| Jun 2020 | - | $660.70 M(+1.6%) |
| Mar 2020 | - | $650.30 M(-0.5%) |
| Dec 2019 | $653.30 M(+10.0%) | $653.30 M(+1.0%) |
| Sep 2019 | - | $646.60 M(+0.3%) |
| Jun 2019 | - | $644.50 M(+0.1%) |
| Mar 2019 | - | $643.60 M(+8.4%) |
| Dec 2018 | $593.80 M(+35.4%) | $593.80 M(+0.0%) |
| Sep 2018 | - | $593.60 M(-0.1%) |
| Jun 2018 | - | $593.90 M(+30.2%) |
| Mar 2018 | - | $456.00 M(+4.0%) |
| Dec 2017 | $438.40 M(-46.7%) | $438.40 M(-57.6%) |
| Sep 2017 | - | $1.03 B(+1.7%) |
| Jun 2017 | - | $1.02 B(+19.9%) |
| Mar 2017 | - | $847.90 M(+3.1%) |
| Dec 2016 | $822.30 M(+37.8%) | $822.30 M(+36.9%) |
| Sep 2016 | - | $600.60 M(-0.3%) |
| Jun 2016 | - | $602.50 M(+0.0%) |
| Mar 2016 | - | $602.20 M(+0.9%) |
| Dec 2015 | $596.90 M(-0.2%) | $596.90 M(-1.3%) |
| Sep 2015 | - | $604.90 M(+0.8%) |
| Jun 2015 | - | $600.30 M(-0.4%) |
| Mar 2015 | - | $602.70 M(+0.8%) |
| Dec 2014 | $598.10 M(+0.8%) | $598.10 M(+0.3%) |
| Sep 2014 | - | $596.40 M(-0.3%) |
| Jun 2014 | - | $598.00 M(-17.6%) |
| Mar 2014 | - | $725.40 M(+22.3%) |
| Dec 2013 | $593.10 M(+213.3%) | $593.10 M(+11.5%) |
| Sep 2013 | - | $532.10 M(+134.1%) |
| Jun 2013 | - | $227.30 M(+18.0%) |
| Mar 2013 | - | $192.70 M(+1.8%) |
| Dec 2012 | $189.30 M | $189.30 M(+7.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2012 | - | $175.40 M(-5.2%) |
| Jun 2012 | - | $185.10 M(+3.2%) |
| Mar 2012 | - | $179.40 M(+19.3%) |
| Dec 2011 | $150.40 M(+66.6%) | $150.40 M(-14.1%) |
| Sep 2011 | - | $175.00 M(+0.1%) |
| Jun 2011 | - | $174.80 M(-1.5%) |
| Jun 2010 | - | $177.50 M(+37.3%) |
| Mar 2010 | - | $129.30 M(+43.2%) |
| Dec 2009 | $90.30 M(-48.5%) | $90.30 M(-11.7%) |
| Sep 2009 | - | $102.30 M(-10.2%) |
| Jun 2009 | - | $113.90 M(-7.4%) |
| Mar 2009 | - | $123.00 M(-29.9%) |
| Dec 2008 | $175.50 M(+184.4%) | $175.50 M(-13.5%) |
| Sep 2008 | - | $202.80 M(+43.1%) |
| Jun 2008 | - | $141.70 M(+125.3%) |
| Mar 2008 | - | $62.90 M(+1.9%) |
| Dec 2007 | $61.70 M(-73.8%) | $61.70 M(+0.8%) |
| Sep 2007 | - | $61.20 M(+6.3%) |
| Jun 2007 | - | $57.60 M(-74.3%) |
| Mar 2007 | - | $224.50 M(-4.8%) |
| Dec 2006 | $235.90 M(-25.4%) | $235.90 M(-6.8%) |
| Sep 2006 | - | $253.00 M(-9.5%) |
| Jun 2006 | - | $279.60 M(-3.3%) |
| Mar 2006 | - | $289.00 M(-8.6%) |
| Dec 2005 | $316.10 M(+18.3%) | $316.10 M(+25.7%) |
| Sep 2005 | - | $251.50 M(-6.7%) |
| Jun 2005 | - | $269.60 M(-2.2%) |
| Mar 2005 | - | $275.80 M(+3.3%) |
| Dec 2004 | $267.10 M(+4.4%) | $267.10 M(-0.8%) |
| Sep 2004 | - | $269.20 M(-13.9%) |
| Jun 2004 | - | $312.80 M(-6.5%) |
| Mar 2004 | - | $334.50 M(+30.8%) |
| Dec 2003 | $255.80 M(+4.2%) | $255.80 M(-12.7%) |
| Sep 2003 | - | $293.10 M(-4.6%) |
| Jun 2003 | - | $307.30 M(+11.0%) |
| Mar 2003 | - | $276.90 M(+12.8%) |
| Dec 2002 | $245.50 M(-20.8%) | $245.50 M(-12.3%) |
| Sep 2002 | - | $279.90 M(-5.7%) |
| Jun 2002 | - | $296.90 M(+2.1%) |
| Mar 2002 | - | $290.80 M(-6.1%) |
| Dec 2001 | $309.80 M(-15.6%) | $309.80 M(-8.6%) |
| Sep 2001 | - | $339.10 M(+0.0%) |
| Jun 2001 | - | $339.00 M(-3.9%) |
| Mar 2001 | - | $352.90 M(-3.8%) |
| Dec 2000 | $367.00 M | $367.00 M(+5.4%) |
| Sep 2000 | - | $348.20 M(+8.5%) |
| Jun 2000 | - | $321.00 M(+0.6%) |
| Mar 2000 | - | $319.00 M |
FAQ
- What is the all time high annual long term debt for Edwards Lifesciences?
- What is the all time high quarterly long term debt for Edwards Lifesciences?
What is the all time high annual long term debt for Edwards Lifesciences?
Edwards Lifesciences all-time high annual long term debt is $822.30 M
What is the all time high quarterly long term debt for Edwards Lifesciences?
Edwards Lifesciences all-time high quarterly long term debt is $1.03 B